In her current role as a Regulatory Specialist for CARE Institute, Natasha oversees regulatory affairs for a portfolio of products in cardiology and nephrology. She is responsible for preparing and submitting        regulatory filings, maintaining product registrations, and ensuring adherence to Good Manufacturing Practices (GMP) and other applicable regulations.

Previously, at Avira Sciences and Molecular Defenses Corporation, Natasha provided clinical trial support for a diverse portfolio of patented therapeutic drugs. She coordinated meetings with investigative clinical research scientists, maintained extensive calendars for management, patent attorneys, corporate legal counsel, and researchers across multiple locations, including Palo Alto, New York, Paris, and Stockholm. Additionally, she managed and maintained a shared database of peer-reviewed published research and facilitated communication with GMP drug clinical compound manufacturers. Natasha is committed to staying up to date with the latest regulatory developments and best practices through continuous professional development.